Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during the COVID-19 Pandemic

Abstract

Background. Although Kawasaki disease (KD) is the most common self-limited systemic vasculitis in pediatrics, the exact etiology of the disease, its association with other diseases, and pathogens is still unknown. In order to achieve a better understanding and management of the disease, documentation and reporting of atypical cases is justified, particularly with the growing number of children with inflammatory syndrome with clinical features simulating KD during the COVID-19 pandemic. Here, we present a case of an atypical case of KD presenting as multisystem inflammatory syndrome (MIS) during the COVID-19 pandemic. Case Presentation. The patient is a 7-year-old girl who developed fever (39°C) and erythematous multiform rash on the abdomen and along with erythema and edema on the extremities. Laboratory evaluation revealed neutrophilia and lymphopenia along with elevated C-reactive protein, erythrocyte sedimentation rate, troponin, lactate dehydrogenase, ferritin, and D-dimer. Although the patient did not fulfill the KD criteria, based on approved guidelines and approaches regarding atypical KD and multisystem inflammatory syndrome in children (MIS-C) during the COVID-19 pandemic, intravenous immunoglobulin along with aspirin was administered for the patients. The patient’s symptoms resolved with an uneventful postdischarge course. Conclusion. Early diagnosis and treatment of patients meeting full or partial criteria for KD are critical to preventing end-organ damage and other long-term complications, especially during times of public crisis and global health emergencies, such as the novel coronavirus pandemic.

Necrotizing autoimmune myositis following coronavirus disease 2019 infection: a case report

“…Various medications and treatments have been proposed for COVID-19 [14][15][16][17], which along with diagnosis, hospital policies, and high vaccination rates, have increased the control over the disease outbreak [18][19][20][21][22]. However, the long-term adverse effects of patients affected by this disease are still unknown, and reports in this regard are limited [23][24][25]. Although NAM has been reported following various infective pathogens, reports regarding post-SARS-CoV-2 infection are limited [3,26].…”

COVID‐19 vaccine‐induced vasculitis in a patient with sarcoidosis: A case report

“…The COVID‐19 pandemic has caused a toll on many aspects of the healthcare system and also patients, and required immediate interventions and actions, some aiming to facilitate diagnosis, 18 , 19 , 20 , 21 , 22 , 23 some to improve treatment, 22 , 24 , 25 , 26 , 27 , 28 , 29 , 30 and some (such as vaccination and applied protocols) aim to subside the spread of the disease. 25 , 29 , 31 , 32 , 33 In the process of emergency production of the COVID‐19 vaccine, immunocompromised patients were not included in the initial studies' study population.…”

Antibiotic Overprescribing among Neonates and Children Hospitalized with COVID-19 in Pakistan and the Implications

“…Viral pneumonia was the commonest presenting condition [ 10 , 12 , 13 ]. However, there are concerns with children developing Kawasaki Disease (KD)-like symptoms, now known as Pediatric Inflammatory Multisystem Syndrome (PIMS-TS), alongside experiencing coagulation disorders as well as respiratory changes and abdominal involvement with COVID-19 [ 14 , 15 , 16 , 17 , 18 , 19 , 20 ]. These combined symptoms increase admission to (PICUs).…”